Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Courtney Marecki

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Vaccine|August 24, 2025
Pre-clinical characterization of virus-like particles as a platform for nanovaccines against heroin and oxycodoneDavide Tronconi, Courtney Marecki, Robert W Seaman, et al.
Journal of Medicinal Chemistry|May 29, 2026
Prophylactic Active Immunization Protects against Xylazine-Induced Pharmacological Effects in RatsCaroline M Kim, Robert W Seaman, Courtney Marecki, et al.
Biomaterials|October 16, 2025
IFN-γ and TLR agonist co-adjuvants enhance the efficacy of a lipid-PLGA hybrid nanoparticle-based oxycodone vaccineYuanzhi Bian, Qiaoqiao Ci, Kobra Rostamizadeh, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 8, 2025
Innate immune mechanisms underlying the efficacy of a next-generation nanoparticle-based vaccine against opioid use disordersFatima A Hamid, Kobra Rostamizadeh, Nicholas Skiados, et al.
ACS Pharmacology & Translational Science|July 15, 2026
Discovery, Structural Characterization, and Preclinical Evaluation of Monoclonal Antibodies against Xylazine PoisoningJason Kang, Ruowen Xu, Shea Lee, et al.
Psychopharmacology|February 5, 2025
A humanized monoclonal antibody attenuates fentanyl self-administration and reverses and prevents fentanyl-induced ventilatory depression in rhesus monkeysLindsey K Galbo-Thomma, Courtney Marecki, Caroline M Kim, et al.
Bioconjugate Chemistry|March 17, 2025
Bivalent Hapten Display Strategies for Conjugate Vaccines Targeting Opioid Mixtures Containing FentanylCarly Baehr, Rajwana Jahan, Ann Gebo, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Vaccine|August 24, 2025
Pre-clinical characterization of virus-like particles as a platform for nanovaccines against heroin and oxycodoneDavide Tronconi, Courtney Marecki, Robert W Seaman, et al.
Journal of Medicinal Chemistry|May 29, 2026
Prophylactic Active Immunization Protects against Xylazine-Induced Pharmacological Effects in RatsCaroline M Kim, Robert W Seaman, Courtney Marecki, et al.
Biomaterials|October 16, 2025
IFN-γ and TLR agonist co-adjuvants enhance the efficacy of a lipid-PLGA hybrid nanoparticle-based oxycodone vaccineYuanzhi Bian, Qiaoqiao Ci, Kobra Rostamizadeh, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 8, 2025
Innate immune mechanisms underlying the efficacy of a next-generation nanoparticle-based vaccine against opioid use disordersFatima A Hamid, Kobra Rostamizadeh, Nicholas Skiados, et al.
ACS Pharmacology & Translational Science|July 15, 2026
Discovery, Structural Characterization, and Preclinical Evaluation of Monoclonal Antibodies against Xylazine PoisoningJason Kang, Ruowen Xu, Shea Lee, et al.
Psychopharmacology|February 5, 2025
A humanized monoclonal antibody attenuates fentanyl self-administration and reverses and prevents fentanyl-induced ventilatory depression in rhesus monkeysLindsey K Galbo-Thomma, Courtney Marecki, Caroline M Kim, et al.
Bioconjugate Chemistry|March 17, 2025
Bivalent Hapten Display Strategies for Conjugate Vaccines Targeting Opioid Mixtures Containing FentanylCarly Baehr, Rajwana Jahan, Ann Gebo, et al.
Pageof 1